Final Agenda
Tuesday, June 30, 2020
11:00 a.m. – 6:00 p.m. EDT
Chair:
Steven Skates, Ph.D., Massachusetts General Hospital
Co-Chair:
Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center
NCI Program Directors:
Christos Patriotis, Ph.D., and Sharmistha Ghosh-Janjigian, Ph.D., National Cancer Institute
11:00 a.m. – 11:05 a.m. EDT |
Welcome and Introductions Steven Skates, Ph.D., Massachusetts General Hospital Christos Patriotis, Ph.D., National Cancer Institute |
11:05 a.m. – 11:45 a.m. EDT |
BGYN01: Objective, Charge and Progress of Collaborative Group Steven Skates, Ph.D., Massachusetts General Hospital Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center |
11:45 a.m. – 12:25 p.m. EDT |
Pros and Cons of Pan-Cancer Detection Approach: Should EDRN Increase Focus on Such an Approach? (10+10 min talk, 20 min discussion) Moderator:Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center |
11:45 a.m. – 11:55 a.m. EDT |
BGYN02: Noninvasive Multi-Cancer Screening Using Liquid Biopsy Nicholas Papadopoulos, Ph.D., Johns Hopkins University School of Medicine |
11:55 a.m. – 12:05 p.m. EDT |
BGYN03: Simultaneous Multi-Cancer Detection using a Cell-free Nucleic Acid Assay Brian Allen, M.S., GRAIL |
12:05 p.m. – 12:25 p.m. EDT |
Discussants: Steven Skates, Ph.D., Massachusetts General Hospital Karen Anderson, M.D., Ph.D., Arizona State University/The Biodesign Institute Zhen Zhang, Ph.D., Johns Hopkins University School of Medicine |
12:25 p.m. – 1:05 p.m. EDT |
Integration of Germline Genomics and Circulating Biomarkers for Early Cancer Detection (20 min talk, 20 min discussion) Moderator:Christos Patriotis, Ph.D., National Cancer Institute |
12:25 p.m. – 12:45 p.m. EDT |
BGYN04: Tailoring Early Detection Strategies for Breast and Ovarian Cancer to Genomic Risk Mary Daly, M.D., Fox Chase Cancer Center |
12:45 p.m. – 1:05 p.m. EDT |
Discussants: Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center Robert Bast, M.D., The University of Texas MD Anderson Cancer Center Yiwey Shieh, M.D., University of California San Francisco |
1:05 p.m. – 1:30 p.m. EDT | Break |
1:30 p.m. – 2:10 p.m. EDT |
ctDNA for Early Cancer Detection Biomarker Development (10+10 min talk, 20 min discussion) Moderator:Sharmistha Ghosh-Janjigian, Ph.D., National Cancer Institute |
1:30 p.m. – 1:40 p.m. EDT |
BGYN05: ctDNA for Early Cancer Detection: Promise, Challenges, and Emerging Solutions Abhijit Patel, M.D., Ph.D., Yale School of Medicine |
1:40 p.m. – 1:50 p.m. EDT |
BGYN06: Cell-free DNA for Early Cancer Detection Xianghong Jasmine Zhou, Ph.D., University of California Los Angeles |
1:50 p.m. – 2:10 p.m. EDT |
Discussants: Nicholas Papadopoulos, Ph.D., Johns Hopkins University School of Medicine Steven Skates, Ph.D., Massachusetts General Hospital |
2:10 p.m. – 2:50 p.m. EDT |
Exosomes and Early Cancer Detection Biomarker Development (10+10 min talk, 20 min discussion) Moderator:Steven Skates, Ph.D., Massachusetts General Hospital |
2:10 p.m. – 2:20 p.m. EDT |
BGYN07: Microfluidics for the Isolation and Tracking of Tumor Extracellular Vesicles Shannon Stott, Ph.D., Massachusetts General Hospital |
2:20 p.m. – 2:30 p.m. EDT |
BGYN08: Exosome Proteomics For Early Cancer Detection David Lyden, M.D., Ph.D., Weill Cornell Medicine, Drukier Institute for Children's Health |
2:30 p.m. – 2:50 p.m. EDT |
Discussants: Johan Skog, Ph.D., Exosome Diagnostics Andrew Godwin, Ph.D., Kansas University Medical Center |
2:50 p.m. – 3:15 p.m. EDT | Break |
3:15 p.m. – 3:55 p.m. EDT |
Exploring the Tumor-Associated Lymphoid Cell Compartment for Advancing the Early Cancer Detection Research Space (10+10 min talk, 20 min discussion) Moderator:Steven Skates, Ph.D., Massachusetts General Hospital |
3:15 p.m. – 3:25 p.m. EDT |
BGYN09: Detect Early-Stage Cancers From the Blood T cell Repertoire Bo Li, Ph.D., University of Texas Southwestern |
3:25 p.m. – 3:35p.m. EDT |
BGYN10: Probing the micro-environment of Breast Pre-cancerous lesions Olivier Harismendy, Ph.D., University of California San Diego |
3:35 p.m. – 3:55 p.m. EDT |
Discussants: Charles Drescher, M.D., Fred Hutchinson Cancer Research Center Jeffrey Marks, Ph.D., Duke University Medical Center |
3:55 p.m. – 4:35 p.m. EDT |
Imaging and Artificial Intelligence in Early Cancer Detection (10+10 min talk, 20 min discussion) Moderator:Christos Patriotis, Ph.D., National Cancer Institute |
3:55 p.m. – 4:05p.m. EDT |
BGYN11: Mammography AI in EDRN Imaging Joseph Lo, Ph.D., Duke University |
4:05 p.m. – 4:15 p.m. EDT |
BGYN12: Implementing AI in early cancer detection Ashish Mahabal, Ph.D., California Institute of Technology/Jet Propulsion Laboratory |
4:15 p.m. – 4:35 p.m. EDT |
Discussants: Victoria Seewaldt, M.D., City of Hope Comprehensive Cancer Center Jennifer Barton, Ph.D., University of Arizona John Heine, Ph.D., H. Lee Moffitt Cancer Center and Research Institute, Inc. |
4:35 p.m. – 4:45 p.m. EDT | Break |
4:45 p.m. – 6:00 p.m. EDT |
SWOT (Strengths, Weaknesses, Opportunities, and Threats) Analysis Moderator: Joshua LaBaer, M.D., Ph.D., Arizona State University/The Biodesign Institute Discussants: Karen Anderson, M.D., Ph.D., Arizona State University/The Biodesign Institute Charles Drescher, M.D., Fred Hutchinson Cancer Research Center Jeffrey Marks, Ph.D., Duke University Medical Center Discuss the strengths of EDRN and suggestions to further strengthen the Network Identify weaknesses and discuss the solutions (Mitigation) Discuss opportunities and highlight prioritized opportunities Discuss threats (competing interests/research) and mitigations |
6:00 p.m. EDT | Adjourn |